Find clinical trials for Prostate Cancer in Montréal, QC
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Prostate Cancer trials near Montréal, QC, CAN:
177Lu PSMA 617 is a new type of therapy which is designed to deliver high doses of radiation directly to prostate cancer sites in t ...
Phase 2
Montreal, Quebec, Canada and 9 other locations
Therapy in men with low-risk to intermediate to high-risk localized prostate cancer who are candidates for, or have opted for, pros...
Montreal, Quebec, Canada and 38 other locations
androgen deprivation therapy (ADT) with a luteinising hormone releasing hormone analogue (LHRHA) in men having radiation therapy for localised prostate...
Phase 3
Montreal, Quebec, Canada and 92 other locations
The purpose of this study is to investigate potential drug-drug interaction (DDI) between JNJ-56021927 and abiraterone acetate and between JNJ-560219...
Phase 1
Montreal, Quebec, Canada and 6 other locations
purpose of this study is to assess the safety, tolerability, and preliminary efficacy of BMS-986460 in men with Metastatic Castration-resistant Prostate...
Phase 1
Montreal, Quebec, Canada and 14 other locations
ACCEL is a multicenter, open label phase Ia/Ib/II study of \[Ac-225\]-PSMA-62 in participants with prostate-specific membrane antigen (PSMA) ...
Phase 1
Montreal, Canada and 6 other locations
and abiraterone in patients with metastatic castration-resistant prostate cancer (mCRPC) who have received no prior cytotoxic chemo ...
Phase 3
Montreal, Quebec, Canada and 131 other locations
The purpose of this study is to find out what effects a new drug, palbociclib, has on prostate cancer and will look at the side eff...
Phase 2
Montreal, Quebec, Canada and 7 other locations
with prostate cancer who received at least one dose of AAA617 from interventional, Phase I-IV Novartis sponsored clinical trials....
Phase 4
Montreal, Quebec, Canada and 53 other locations
with high-risk and very high-risk localised/locally advanced prostate cancer with a breast cancer gene mutation (BRCAm)....
Phase 3
Montreal, Quebec, Canada and 345 other locations
Clinical trials
Research sites
Resources
Legal